How much funding has General Proximity raised?

General Proximity has raised $16.0M in total funding, most recently a venture unknown round.

Who are General Proximity's investors?

General Proximity's investors include Felicis Ventures, age1, Y Combinator, Rock Creek Capital.

When was General Proximity founded?

General Proximity was founded in 2019.

Where is General Proximity headquartered?

General Proximity is headquartered in San Francisco, California, United States.

What industry is General Proximity in?

General Proximity operates in Biotech, Drug Discovery, Healthcare.

How many employees does General Proximity have?

General Proximity has 11-50 employees.

General Proximity

The next generation of induced-proximity medicines.

San Francisco, United States · Founded 2019 · $16.0M raised

Biotech

Drug Discovery

Healthcare

YC W20

Headquarters: San Francisco, California
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: generalproximity.bio
Total Funding: $16.0M
Last Round: $8.0M Venture RoundMay 2026
Rounds: 3

About

General Proximity is a San Francisco biotechnology platform company pioneering next-generation induced proximity medicines for undruggable targets. Its proprietary OmniTAC platform enables precise modification of disease-driving proteins across oncology, cardiometabolic disease, neurodegeneration, and longevity. Backed by Felicis, Y Combinator, age1, and ARPA-H grants.

Summary

General Proximity is a Biotech company based in San Francisco, United States, founded in 2019. It has raised $16.0M in total across 3 rounds, most recently a $8.0M Venture Round round in May 2026. Investors include Felicis Ventures, age1 and Y Combinator.